BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 27723532)

  • 1. Green tea (Cammellia sinensis) attenuates ventricular remodeling after experimental myocardial infarction.
    Lustosa BB; Polegato B; Minicucci M; Rafacho B; Santos PP; Fernandes AA; Okoshi K; Batista D; Modesto P; Gonçalves A; Pereira EJ; Pires V; Paiva S; Zornoff L; Azevedo PS
    Int J Cardiol; 2016 Dec; 225():147-153. PubMed ID: 27723532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosemary supplementation (Rosmarinus oficinallis L.) attenuates cardiac remodeling after myocardial infarction in rats.
    Murino Rafacho BP; Portugal Dos Santos P; Gonçalves AF; Fernandes AAH; Okoshi K; Chiuso-Minicucci F; Azevedo PS; Mamede Zornoff LA; Minicucci MF; Wang XD; Rupp de Paiva SA
    PLoS One; 2017; 12(5):e0177521. PubMed ID: 28494028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green Tea (
    Modesto PN; Polegato BF; Dos Santos PP; Grassi LDV; Molina LCC; Bazan SGZ; Pereira EJ; Fernandes AAH; Fabro AT; Androcioli VN; Roscani MG; de Paiva SAR; Zornoff LAM; Minicucci MF; Azevedo PS
    Oxid Med Cell Longev; 2021; 2021():8898919. PubMed ID: 34035878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Administration of Eicosapentaenoic Acid Improves Post-Myocardial Infarction Cardiac Remodeling in Mice by Regulating Macrophage Polarization.
    Takamura M; Kurokawa K; Ootsuji H; Inoue O; Okada H; Nomura A; Kaneko S; Usui S
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28223437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
    Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
    Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J; Zhou J; Ding X; Zhu L; Jiang K; Fu M; Wang S; Hu K; Ge J
    Int J Clin Exp Pathol; 2015; 8(6):6596-606. PubMed ID: 26261541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spondias mombin L. attenuates ventricular remodelling after myocardial infarction associated with oxidative stress and inflammatory modulation.
    Pereira BLB; Rodrigue A; Arruda FCO; Bachiega TF; Lourenço MAM; Correa CR; Azevedo PS; Polegato BF; Okoshi K; Fernandes AAH; de Paiva SAR; Zornoff LAM; Power KA; Minicucci MF
    J Cell Mol Med; 2020 Jul; 24(14):7862-7872. PubMed ID: 32468694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Re Preserves Cardiac Function and Ameliorates Left Ventricular Remodeling in a Rat Model of Myocardial Infarction.
    Yu Y; Sun J; Liu J; Wang P; Wang C
    J Cardiovasc Pharmacol; 2020 Jan; 75(1):91-97. PubMed ID: 31599782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
    Yurista SR; Silljé HHW; Oberdorf-Maass SU; Schouten EM; Pavez Giani MG; Hillebrands JL; van Goor H; van Veldhuisen DJ; de Boer RA; Westenbrink BD
    Eur J Heart Fail; 2019 Jul; 21(7):862-873. PubMed ID: 31033127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trimetazidine, a partial inhibitor of fatty acid oxidation, on ventricular function and survival after myocardial infarction and reperfusion in the rat.
    Mouquet F; Rousseau D; Domergue-Dupont V; Grynberg A; Liao R
    Fundam Clin Pharmacol; 2010 Aug; 24(4):469-76. PubMed ID: 20030737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive left ventricular remodeling, myocyte apoptosis, and protein signaling cascades after myocardial infarction in rabbits.
    Qin F; Liang MC; Liang CS
    Biochim Biophys Acta; 2005 Jun; 1740(3):499-513. PubMed ID: 15949720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
    Rathinavel A; Sankar J; Mohammed Sadullah SS; Niranjali Devaraj S
    Fundam Clin Pharmacol; 2018 Feb; 32(1):51-59. PubMed ID: 29059499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the tissue inhibitor of metalloproteinase-3 by transplanted VSMCs modifies heart structure and function after myocardial infarction.
    Jia ZB; Tian H; Kang K; Miao HZ; Liu KY; Jiang SL; Wang LP
    Transpl Immunol; 2014 May; 30(4):149-58. PubMed ID: 24727088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
    Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
    Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.
    Buss SJ; Muenz S; Riffel JH; Malekar P; Hagenmueller M; Weiss CS; Bea F; Bekeredjian R; Schinke-Braun M; Izumo S; Katus HA; Hardt SE
    J Am Coll Cardiol; 2009 Dec; 54(25):2435-46. PubMed ID: 20082935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic exploration of the potential material basis and molecular mechanism of the Mongolian medicine Nutmeg-5 in improving cardiac remodeling after myocardial infarction.
    Liu T; Yan T; Jia X; Liu J; Ma R; Wang Y; Wang X; Liang Y; Xiao Y; Dong Y
    J Ethnopharmacol; 2022 Mar; 285():114847. PubMed ID: 34800647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.
    Zhang Y; Elsik M; Edgley AJ; Cox AJ; Kompa AR; Wang B; Tan CY; Khong FL; Stapleton DI; Zammit S; Williams SJ; Gilbert RE; Krum H; Kelly DJ
    Int J Cardiol; 2013 Sep; 168(2):1174-85. PubMed ID: 23219315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.